Press Releases July 7, 2026 08:30 AM

Trust Stamp joins the European Union Semiconductor Initiative (IPCEI AST) with the Support of Malta Enterprise

Trust Stamp joins EU's major semiconductor initiative to advance secure device identity and biometric technology

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
IDAI

Trust Stamp announces its Maltese subsidiary's selection as a direct participant in the EU's Important Project of Common European Interest on Advanced Semiconductor Technologies (IPCEI AST). The partnership aims to develop a secure semiconductor identity platform linking device identity with verified human identity, leveraging biometric tokenization, and explore AI-supported neural signal processing, strengthening Europe's semiconductor sovereignty and security.

Trust Stamp joins the European Union Semiconductor Initiative (IPCEI AST) with the Support of Malta Enterprise
IDAI
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Trust Stamp Malta Limited joins EU’s IPCEI AST, a significant coordinated initiative to boost advanced semiconductor technologies and security.
  • Collaboration to develop hardware-rooted security platforms combining biometric tokenization to ensure devices operate only in authorized hands, impacting communications, IoT, and safety-critical systems sectors.
  • Exploration of AI-assisted processing of neural signal data for brain-computer interfaces, highlighting Trust Stamp's role in securing sensitive biometric data at the chipset level.

ATLANTA, GA, July 07, 2026 (GLOBE NEWSWIRE) -- Trust Stamp (Nasdaq: IDAI), today announced that its Maltese subsidiary, Trust Stamp Malta Limited, has been selected as a direct participant in the Important Project of Common European Interest on Advanced Semiconductor Technologies (IPCEI AST), with the support of Malta Enterprise.

The IPCEI AST is a major, coordinated European initiative backed by participating EU Member States and their national authorities, with the objective of strengthening Europe's sovereignty, security and resilience across the advanced semiconductor value chain. Bringing together industry and research participants from across the EU, it is designed to accelerate the development and first industrial deployment of next-generation chip technologies. IPCEI is one of the EU's principal instruments for funding strategic technologies; its predecessor in microelectronics, IPCEI ME/CT, mobilised up to €8.1 billion in public funding across fourteen Member States. The overall funding envelope for the Advanced Semiconductor Technologies wave is still being finalised.

Trust Stamp's selection positions its privacy-first identity technology within this strategic effort by binding the identity of a device to a verified human identity, so that critical hardware can be trusted to operate only in authorised hands. This work will build on Trust Stamp's patented approach to irreversible biometric tokenization, which protects personal data while enabling strong, privacy-preserving authentication.

Trust Stamp's participation is anchored by two cooperation agreements planned to run over the project period (2027 - 2032), subject to formal approval:

  • A secure semiconductor identity platform: a collaboration to design a platform that links device identity to a verified human identity, combining hardware-rooted security (including memristor-based physically unclonable functions) with Trust Stamp's biometric tokenization to help prevent the unauthorised use of critical devices across communications, IoT and safety-critical systems.
  • AI-supported processing of neural signals: a collaboration exploring the AI-assisted processing and analysis of neural-signal data generated by an emerging biosignal-chip platform, paired with secure device authentication to protect highly sensitive data at the hardware level.

Trust Stamp's participation in the program has been made possible with the support of Malta Enterprise, Malta's national economic development agency, which coordinates and champions Malta's involvement in the IPCEI AST. Malta Enterprise's backing reflects a shared commitment to position Malta and its innovators within Europe's most strategic technology programmes, and to build a local ecosystem spanning industry and academic partners around advanced semiconductor and secure-identity technology.

Berta Pappenheim, a Trust Stamp Executive Director and the project lead commented, "Being selected as a direct participant in the program is an important milestone for Trust Stamp. It lets us bring our privacy-first identity technology to one of the European Union’s most strategic industrial programmes, working alongside strong international partners to ensure that critical devices can be trusted to operate only in authorised hands. We are especially excited to explore the emerging field of brain-computer interfaces and to bring our expertise to securing the uniquely sensitive neural datasets these systems generate. We are grateful to Malta Enterprise for the support that makes Malta's contribution possible, and we look forward to helping grow the local ecosystem around this work."

Inquiries:
Trust Stamp                                                   Email: [email protected]

About Trust Stamp

Trust Stamp is a global provider of AI-powered services for use in multiple sectors including banking and finance, regulatory compliance, government, healthcare, real estate, communications, and humanitarian services. Its technology empowers organizations via advanced solutions that reduce fraud, tokenize and secure data, securely authenticate users while protecting personal privacy, reduce friction in digital transactions, and increase operational efficiency, enabling customers to accelerate secure financial inclusion and reach and serve a broader base of users worldwide.

With team members from twenty-two nationalities in eight countries across North America, Europe, Asia, and Africa, Trust Stamp trades on the Nasdaq Capital Market (Nasdaq: IDAI).

Safe Harbor Statement: Caution Concerning Forward-Looking Remarks 

All statements in this release that are not based on historical fact are “forward-looking statements” including within the meaning of the Private Securities Litigation Reform Act of 1995 and the provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The information in this announcement may contain forward-looking statements and information related to, among other things, the company, its business plan and strategy, and its industry. These statements reflect management’s current views with respect to future events-based information currently available and are subject to risks and uncertainties that could cause the company’s actual results to differ materially from those contained in the forward-looking statements. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made. The company does not undertake any obligation to revise or update these forward-looking statements to reflect events or circumstances after such date or to reflect the occurrence of unanticipated events.


Risks

  • The funding envelope for the IPCEI AST initiative is still being finalized, which could impact project resources and timelines affecting Trust Stamp's development plans.
  • Projected cooperation agreements are subject to formal approval, introducing potential uncertainty in the continuity and scope of project involvement.
  • Broader market and technological risks include reliance on emerging AI, biometric, and semiconductor technologies with evolving regulatory and implementation challenges.

More from Press Releases

Texxon Holding Limited Announces Commencement of Operations at Henan Polystyrene Production Facility, A Milestone in Manufacturing Expansion Strategy Jul 7, 2026 Columbia Financial, Inc. Commences Firm Commitment Underwritten Offering Jul 7, 2026 Diana Shipping Inc. Announces Time Charter Contract for m/v Medusa with Aquavita Jul 7, 2026 Virtuix Signs Strategic Partnership with Sirica Therapeutics to Advance AI-Driven Autism Therapy Jul 7, 2026 XWELL Announces Definitive Agreement to Divest XpresSpa and XpresTest Businesses Jul 7, 2026